肥胖相关炎症诱导前列腺雄激素向雌激素转化
研究探讨肥胖、炎症与类固醇激素如何影响良性前列腺增生(BPH)发生,使用前脂肪细胞、巨噬细胞、人前列腺基质细胞、高脂饮食肥胖小鼠前列腺组织及35例经尿道前列腺电切术(TURP)患者标本,检测SRD5A2启动子甲基化、性激素及炎症介质。结果显示肥胖前列腺组织炎症介质升高、SRD5A2启动子甲基化增强且表达受抑,炎症介质与饱和脂肪酸协同调节芳香化酶活性,肥胖促进前列腺雄激素向雌激素转化。
要点
- 肥胖前列腺组织炎症介质升高,SRD5A2启动子甲基化增强、表达受抑
- 炎症介质与饱和脂肪酸协同调节芳香化酶活性
- 肥胖促进前列腺内雄激素向雌激素转化
核心结论
- 肥胖相关炎症诱导前列腺雄激素向雌激素转化,可能为部分BPH相关下尿路症状的替代治疗提供策略。
研究设计与样本
- 使用前脂肪细胞、巨噬细胞、人前列腺基质细胞、高脂饮食诱导肥胖小鼠前列腺组织及35例TURP患者前列腺标本。
主要发现
- 肥胖前列腺组织中炎症介质水平升高。
- SRD5A2启动子甲基化增强而SRD5A2表达受抑。
- 炎症介质与饱和脂肪酸协同调节芳香化酶活性。
- 肥胖促进前列腺雄激素向雌激素转化。
临床怎么用
- 对部分BPH相关下尿路症状患者,肥胖相关炎症及雄雌激素转化可能作为替代治疗策略的参考方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Our patient cohort revealed that obesity is strongly associated with steroid-5α reductase type 2 (SRD5A2) promoter methylation and reduced protein expression. The underlying mechanism of prostatic growth in this population is poorly understood. Here we addressed the question of how obesity, inflammation, and steroid hormones affect the development of benign prostatic hyperplasia (BPH). MATERIAL AND METHODS: We used preadipocytes, macrophages, primary human prostatic stromal cells, prostate tissues from high-fat diet-induced obese mice, and 35 prostate specimens that were collected from patients who underwent transurethral resection of the prostate (TURP). RNA was isolated and quantified with RT-PCR. Genome DNA was extracted and SRD5A2 promoter methylation was determined. Sex hormones were determined by high-performance liquid chromatography-tandem mass spectrometry. Protein was extracted and determined by ELISA test. RESULTS: In prostatic tissues with obesity, the levels of inflammatory mediators were elevated. SRD5A2 promoter methylation was promoted, but SRD5A2 expression was inhibited. Inflammatory mediators and saturated fatty acid synergistically regulated aromatase activity. Obesity promoted an androgenic to estrogenic switch in the prostate. CONCLUSIONS: Our findings suggest that obesity-associated inflammation induces androgenic to estrogenic switch in the prostate gland, which may serve as an effective strategy for alternative therapies for management of lower urinary tract symptoms associated with BPH in select individuals.
引用
- Xue B, Wu S, Sharkey C, et al. Obesity-associated inflammation induces androgenic to estrogenic switch in the prostate gland. Prostate Cancer Prostatic Dis. 2020. PMID: 32029929. doi:10.1038/s41391-020-0208-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。